Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Glucocorticoids promote a glioma stem cell-like phenotype and resistance to chemotherapy in human glioblastoma primary cells: Biological and prognostic significance

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Testicular cancer incidence predictions in Europe 2010–2035: A rising burden despite population ageing

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association Consortium

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Tibolone and risk of gynecological hormone sensitive cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Does HPV status influence survival after vulvar cancer?

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3-A Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Impact of meningioma surgery on use of antiepileptic, antidepressant, and sedative drugs: A Swedish nationwide matched cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. TERT promoter mutations in primary and secondary WHO grade III meningioma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Expression of the stem cell marker CD133 in malignant meningioma

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. The Ki-67 Proliferation Index as a Marker of Time to Recurrence in Intracranial Meningioma

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Ourania N Kostopoulou
  • Abdul-Aleem Mohammad
  • Jiri Bartek
  • Julia Winter
  • Masany Jung
  • Giuseppe Stragliotto
  • Cecilia Söderberg-Nauclér
  • Natalia Landázuri
View graph of relations

Glioma stem cells (GSCs) are glioblastoma (GBM) cells that are resistant to therapy and can give rise to recurrent tumors. The identification of patient-related factors that support GSCs is thus necessary to design effective therapies for GBM patients. Glucocorticoids (GCs) are used to treat GBM-associated edema. However, glucocorticoids participate in the physiological response to psychosocial stress, which has been linked to poor cancer prognosis. This raises concern that glucocorticoids affect the tumor and GSCs. Here, we treated primary human GBM cells with dexamethasone and evaluated GC-driven changes in cell morphology, proliferation, migration, gene expression, secretory activity and growth as neurospheres. Dexamethasone treatment of GBM cells appeared to promote the development of a GSC-like phenotype and conferred resistance to physiological stress and chemotherapy. We also analyzed a potential correlation between GC treatment and tumor recurrence after surgical excision in a population-based consecutive cohort of 48 GBM patients, adjusted for differences in known prognostic factors concerning baseline and treatment characteristics. In this cohort, we found a negative correlation between GC intake and progression-free survival, regardless of the MGMT methylation status. In conclusion, our findings raise concern that treatment of GBM with GCs may compromise the efficacy of chemotherapy and may support a GSC population, which could contribute to tumor recurrence and the poor prognosis of the disease.

Original languageEnglish
JournalRadiation Oncology Investigations
Volume142
Issue number6
Pages (from-to)1266-1276
ISSN0020-7136
DOIs
Publication statusPublished - 2018

    Research areas

  • Journal Article

ID: 52379374